CD21 antibody
Principal name
CD21 antibody
Alternative names for CD21 antibody
Complement receptor type 2, CR2, C3DR, C3d receptor, EBV Receptor, Dendritic Cell Marker, Complement C3d receptor, Epstein-Barr virus receptor
Gene ID
1380 (CR2)
Ncbi ID
9606, 9615, 9913, NP_001006659, NP_004235, NM_001877, NP_001868, NM_001006658
Available reactivities
Available hosts
Available applications
Paraffin Sections (P), Flow Cytometry (F), Immunocytochemistry/Immunofluorescence (ICC/IF), Frozen Sections (C), Immunoprecipitation (IP), Western blot / Immunoblot (WB), Functional assay (FN), Enzyme Immunoassay (E)
Selected product citations ‐ of AM08109RP-N
1. Rahe, MC;Murtaugh, MP. Interleukin-21 Drives Proliferation and Differentiation of Porcine Memory B Cells into Antibody Secreting Cells. PLoS ONE 2017, e0171171, 12, 1. PubMed PMID: 28125737.
Background of CD21 antibody
The CD21 antigen is expressed on mature B cells, follicular dendritic cells and pharyngeal and cervical epithelial cells [1,2]. CD21, also known as the Complement receptor type 2 (CR2) or Epstein-Barr virus (EBV) receptor, is a receptor for the C3 activation fragments iC3b and C3d. CD21 is part of a multimeric complex on B cells which includes CD19 and CD81 [3]. The ligand for CD21 is generated during activation of complement by the attachment of C3d to potential antigen. This creates fusion proteins that may cross-link the CD19-CD21-CD81 complex to sIg on antigen-specific B cells. The resulting signal transduction lowers the threshold for cellular activation. This enables an antibody reaction to natural protein antigens containing only one or a few epitopes and therefore unable to effectively cross-link Ig molecules on specific B cells. For example, keyhole limpet hemocyanin (KLH) immune complexes can be taken up and processed by all CR2-bearing B cells, regardless of their antigen specificity. KLH immune complexes taken up this way by non-specific B cells were shown to be presented to KLH-specific, MHC class II Th cells. CD23 may also serve as a ligand for CD21 [3].
General readings
1. Tedder T.F., L.T. Clement, and Cooper M.D.. Expression of C3d receptors during human B cell differentiation:
Immunofluorescence analysis with the HB-5 monoclonal antibody. J Immunol. 1984:133:678.
2. Denham, S., R.J. Zwart, J.T.D. Whittall, M. Pampusch, A.H. Corteyn, A.T.J. Bianchi, M.P. Murtaugh, R.M.E. Parkhouse, H.
Tlaskalova, J. Sinkora, M. Siinkora, and Z. Rehakova. 1998. Monoclonal antibodies putatively identifying porcine B cells.
Veter. Immunol. Immunopathol. 60:317-328.
3. Pescovitz, M. Personal communication.
























- Quick-Filters:
- Cited (1)
- Highly Validated (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AM31230PU-N | CD21 antibody |
||||||
![]() |
Mouse | IgG2a | B-E5 | Purified | Hu | F, P |
2ml (200T) /
$320.00
|
| OriGene Technologies GmbH | |||||||
| AM31230RP-N | CD21 antibody |
||||||
![]() |
Mouse | IgG2a | B-E5 | PE | Hu | F |
1ml (100T) /
$390.00
|
| OriGene Technologies GmbH | |||||||
| AM32139PU-N | CD21 antibody |
||||||
![]() |
Mouse | IgG2a | 4C5 | Ig Fraction | Hu | C, ICC/IF |
1 ml /
$430.00
|
| OriGene Technologies GmbH | |||||||
| AM32268SU-N | CD21 antibody |
||||||
![]() |
Mouse | IgG2a | 2G9 | Supernatant | Hu | C, P |
1 ml /
$700.00
|
| OriGene Technologies GmbH | |||||||
| AM39015FC-N | CD21 antibody |
||||||
![]() |
Mouse | IgG1 | B-ly4 | FITC | Hu | F |
100 Tests /
$400.00
|
| OriGene Technologies GmbH | |||||||
| AM39015PU-N | CD21 antibody |
||||||
![]() |
Mouse | IgG1 | B-ly4 | Aff - Purified | Hu | C, F |
1 ml /
$270.00
|
| OriGene Technologies GmbH | |||||||
| AM39015RP-N | CD21 antibody |
||||||
![]() |
Mouse | IgG1 | B-ly4 | PE | Hu | F |
100 Tests /
$470.00
|
| OriGene Technologies GmbH | |||||||
| AP17240PU-N | CD21 (C-term) antibody |
||||||
![]() |
Rabbit | Hu | F, P, WB |
0.4 ml /
$415.00
|
|||
| OriGene Technologies GmbH | |||||||
+2 additional images |
|||||||
| DM028 | CD21 antibody |
||||||
![]() |
Mouse | IgG1 | 1F8 | Supernatant | Hu | P |
1 ml /
$620.00
|
| OriGene Technologies GmbH | |||||||
| DM028-05 | CD21 antibody |
||||||
![]() |
Mouse | IgG1 | 1F8 | Supernatant | Hu | P |
0.5 ml /
$400.00
|
| OriGene Technologies GmbH | |||||||
| SM1785F | CD21 antibody |
||||||
![]() |
Mouse | IgG1 | LB21 | FITC | Hu | F |
0.1 mg /
$400.00
|
| OriGene Technologies GmbH | |||||||
| SM1785FT | CD21 antibody |
||||||
![]() |
Mouse | IgG1 | LB21 | FITC | Hu | F |
25 µg /
$180.00
|
| OriGene Technologies GmbH | |||||||
| SM1785R | CD21 antibody |
||||||
![]() |
Mouse | IgG1 | LB21 | PE | Hu | F |
100 Tests /
$480.00
|
| OriGene Technologies GmbH | |||||||
| SM1785RT | CD21 antibody |
||||||
![]() |
Mouse | IgG1 | LB21 | PE | Hu | F |
25 Tests /
$220.00
|
| OriGene Technologies GmbH | |||||||
| DDX0120P-100 | CD21 (CD21L) antibody |
||||||
![]() |
Mouse | IgG1 | 7D6 | Purified | Hu | C |
0.1 mg /
$440.00
|
| Dendritics SAS | |||||||
+1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP321379 | CD21 (transcript variant 2) |
||||
| Recombinant protein of human complement component (3d/Epstein Barr virus) receptor 2 (CR2), transcript variant 2 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
$788.00
|
|
| OriGene Technologies, Inc. | |||||
ELISA Kits
| Catalog No. | ||
|---|---|---|
| EA100789 | Human CD21/CR2 ELISA Kit |
|
![]() |
1 kit /
$500.00
|
|
| OriGene Technologies, Inc. | ||
| EA101202 | Human CD21 ELISA Kit |
|
![]() |
1 kit /
$250.00
|
|
| OriGene Technologies, Inc. | ||
| EA101203 | Human CD21 ELISA Kit |
|
![]() |
1 kit /
$425.00
|
|
| OriGene Technologies, Inc. | ||
| EA101204 | Human CD21 ELISA Kit |
|
![]() |
1 kit /
$645.00
|
|
| OriGene Technologies, Inc. |

































+2 additional images



